THE GREAT AWAKENING: Alternative News, Health and other interesting readings for those who want to wake up. If you want to change the world, be the Change. "I can't change the direction of the wind, but I can adjust my sails to always reach my destination". Jimmy Dean
Pfizer is expanding its recall of anti-smoking drug Chantix after testing found high levels of carcinogenic material in the pill. The leading prescription for smoking secession, Chantix is prescribed to over half a million people each year and accounts for $1.1 BILLION in revenue for Pfizer each year.
While commercial cigarettes are undoubtedly unhealthy, the market for pharmaceutical cessation products is enormous. So is the money spent on advertising. Pfizer spends over $200 million a year to promote the drug (which is over 400% more expensive than it was in 2008).
By GreatGameIndia – July 4, 2021 | Written by Moira McCarthy – Healthline
In a recent interview former Food and Drug Administration (FDA) advisor turned whistleblower exposed how the FDA approves harmful drugs. The post Former Advisor Now Whistleblower Exposes How FDA Approves Harmful Drugs appeared first on GreatGameIndia.
CCHR hopes study will put an end to the psychiatric practice of pre-drugging children with powerful psychotropic drugs to prevent the possible onset of a behavioral disorder. Experts condemn the practice as unscientific and harmful.
A new study has found prescribing antipsychotics to prevent psychosis is harmful and should put this practice to rest. For a decade CCHR has opposed “pre-drugging” youths and adults to theoretically prevent the onset of behavioral disorders that physically don’t exist. Researchers of the new study published in July in the Australian & New Zealand Journal of Psychiatry, vindicates CCHR’s concerns. Researchers investigated whether antipsychotics might prevent “conversion to psychosis” in people who were identified as at “clinical high risk (CHR)” of it. However, they concluded: